Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease

A method for preventing or treating vascular hyperreactivity in which a chemical compound that is an estrogen beta receptor agonist is administered to a subject suffering from or at risk of vascular hyperreactivity. Preferably, the administration is topically to the skin.

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: HERMSMEYER R. KENT
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HERMSMEYER R. KENT
description A method for preventing or treating vascular hyperreactivity in which a chemical compound that is an estrogen beta receptor agonist is administered to a subject suffering from or at risk of vascular hyperreactivity. Preferably, the administration is topically to the skin.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2010152144A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2010152144A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2010152144A13</originalsourceid><addsrcrecordid>eNqNyjEKwkAQRuE0FqLeYcBayMZ4AJGIvVpZhHHzGxfC7jIzCXh7U3gAqwcfb1k8GjVJPSI9YUwCj2xJiPsUg5qSJcqCCdFoZkE3epC9QTqjBPtQepFn6UKaWP04sFAXFKxYF4sXD4rNr6tie25up8sOObXQzB4R1t6vVelKd6hcXR_d_r_rC5tAPM8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease</title><source>esp@cenet</source><creator>HERMSMEYER R. KENT</creator><creatorcontrib>HERMSMEYER R. KENT</creatorcontrib><description>A method for preventing or treating vascular hyperreactivity in which a chemical compound that is an estrogen beta receptor agonist is administered to a subject suffering from or at risk of vascular hyperreactivity. Preferably, the administration is topically to the skin.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20100617&amp;DB=EPODOC&amp;CC=US&amp;NR=2010152144A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20100617&amp;DB=EPODOC&amp;CC=US&amp;NR=2010152144A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HERMSMEYER R. KENT</creatorcontrib><title>Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease</title><description>A method for preventing or treating vascular hyperreactivity in which a chemical compound that is an estrogen beta receptor agonist is administered to a subject suffering from or at risk of vascular hyperreactivity. Preferably, the administration is topically to the skin.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEKwkAQRuE0FqLeYcBayMZ4AJGIvVpZhHHzGxfC7jIzCXh7U3gAqwcfb1k8GjVJPSI9YUwCj2xJiPsUg5qSJcqCCdFoZkE3epC9QTqjBPtQepFn6UKaWP04sFAXFKxYF4sXD4rNr6tie25up8sOObXQzB4R1t6vVelKd6hcXR_d_r_rC5tAPM8</recordid><startdate>20100617</startdate><enddate>20100617</enddate><creator>HERMSMEYER R. KENT</creator><scope>EVB</scope></search><sort><creationdate>20100617</creationdate><title>Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease</title><author>HERMSMEYER R. KENT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2010152144A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HERMSMEYER R. KENT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HERMSMEYER R. KENT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease</title><date>2010-06-17</date><risdate>2010</risdate><abstract>A method for preventing or treating vascular hyperreactivity in which a chemical compound that is an estrogen beta receptor agonist is administered to a subject suffering from or at risk of vascular hyperreactivity. Preferably, the administration is topically to the skin.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2010152144A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T00%3A05%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HERMSMEYER%20R.%20KENT&rft.date=2010-06-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2010152144A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true